Search

everythinglearnresearchcommunity

for

Search:↓

A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.

IGF2BP3 and other m6A-related genes are linked to keloid formation and could be potential treatment targets.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

A new model helps study acne and test treatments.

Some treatments for multiple sclerosis can cause hair loss.

Artificial skin grafts face immune rejection, but stem cells may improve future designs.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Mesenchymal stem cell secretome shows promise for skin treatments but needs more human trials.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

Fractional CO2 laser therapy effectively improves skin conditions and recovery when combined with other treatments.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

Pericytes can both help and hinder wound healing, needing more research for effective use in treatments.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Common hair loss disorders may not need stem cell therapy, but could benefit from other treatments like hair cycle control and immune restoration therapy.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

A child with low platelets and anemia was later found to have lupus.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

A Laotian man with unusual skin changes and multiple growths in his gut was diagnosed with Cronkhite-Canada Syndrome and improved with nutritional and immune-based treatments.

Different types of hidradenitis suppurativa need specific treatments based on unique skin cell issues.

A gene-based model predicts lung adenocarcinoma outcomes and helps guide treatment decisions.

Skin bacteria help heal wounds and restore healthy skin.